Error: Could not add to watchlist. X

TG Therapeutics Inc

+ Watchlist
NKB2:GR
Frankfurt
11.44
EUR
0.69
6.40%
As of 15:38:36 ET on 08/28/2015.
Open
11.01
Day Range
10.94 - 11.44
Volume
1,000
Previous Close
10.75
52Wk Range
6.39 - 18.44
1 Yr Return
77.56%
Open
11.01
Day Range
10.94 - 11.44
Volume
1,000
Previous Close
10.75
52Wk Range
6.39 - 18.44
1 Yr Return
77.56%
YTD Return
-12.83%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (m EUR)
600.878
Shares Outstanding (m)
52.547
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
TG Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of innovative pharmaceutical products for the treatment of cancer and other underserved therapeutic needs. Currently, the company is developing two therapies targeting hematological malignancies, specifically, relapsed and refractory non-Hodgkins lymphoma.
ADDRESS
787 Seventh Avenue
48th Floor
New York, NY 10019
United States
PHONE
1-212-554-4484
  • Michael S Weiss "Mike"
    Chairman/Interim Pres & CEO
  • Sean A Power
    CFO/Treasurer/Secretary
  • Jenna Bosco
    Director:Investor Relations
Show More